A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
A Multi-Step Approach for Accurate & Timely Data
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayMarket Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
Allergan, an AbbVie company, announced Feb. 25 that it had submitted a new drug application (NDA) to the US FDA for AGN-190584 (pilocarpine 1.25%) ophthalmic solution for symptoms of presbyopia. Th...
AcuFocus announced Feb. 23 that it had submitted a premarket approval (PMA) application to the US FDA for its IC-8 small aperture IOL. The IC-8 is an aspheric monofocal lens that features an embedd...
Alcon reported Feb. 23 that full-year 2020 revenue totaled $6.8 billion, a decrease of 8 percent on a reported and constant currency basis, from $7.4 billion in 2019. The company said a substantial...
Ophthalmologist Hema Ramkumar, MD, won the 2021 Winning Pitch Challenge—Retina, a virtual competition held Feb. 6. Ramkumar, a surgeon at Retina Consultants of Orange County, is the founder of Ocul...
Swiss ophthalmic surgical instrument maker Oertli announced Feb. 17 that it had started construction on a new factory at its location in Berneck. The three-story production and logistics building w...
I-MED Pharma, of Montreal, Canada, announced Feb. 2 that Keir Surgical had taken ownership of its ophthalmic surgical portfolio. No financial details were given. I-MED said it would reinvest the pr...
Medicom Healthcare Limited, of the UK, announced Feb. 10 that it had acquired the product dossier of bimatoprost 0.3 mg/mL, 3ml, preservative-free eye drop solution from Spain’s Famar Health Care S...
Ocugen announced Feb. 23that the European Commission had granted orphan medicinal product designation for its OCU400 gene therapy candidate for retinitis pigmentosa (RP) and Leber congenital amauro...
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.